Climb Bio, Inc. logo

Climb Bio, Inc. (CLYM) Q2 2024 Earnings

CLYM·Reported August 14, 2024·Before market open

Diluted EPS came in at $-1.81.

Diluted EPS
$-1.81
SEC

SEC Filings

Earnings release8-K not filed yet

Financial Snapshot

Trailing eight quarters through Q2 2024

Net Income

View metric

Operating Cash Flow

View metric

EPS (Diluted)

View metric

Q2 2024 Earnings FAQ

Common questions about Climb Bio, Inc.'s Q2 2024 earnings report.

Climb Bio, Inc. (CLYM) reported Q2 2024 earnings on August 14, 2024 before market open.

Climb Bio, Inc. reported diluted EPS of $-1.81 for Q2 2024.

You can read the 10-Q periodic report (0000950170-24-096626) directly on SEC EDGAR. The filing index links above go to sec.gov.